Skip to main content
Top
Published in: European Journal of Applied Physiology 3/2012

01-03-2012 | Original Article

Acute short-term hyperoxia followed by mild hypoxia does not increase EPO production: resolving the “normobaric oxygen paradox”

Authors: Tadej Debevec, Michail E. Keramidas, Barbara Norman, Thomas Gustafsson, Ola Eiken, Igor B. Mekjavic

Published in: European Journal of Applied Physiology | Issue 3/2012

Login to get access

Abstract

Recent findings suggest that besides renal tissue hypoxia, relative decrements in tissue oxygenation, using a transition of the breathing mixture from hyperoxic to normoxic, can also stimulate erythropoietin (EPO) production. To further clarify the importance of the relative change in tissue oxygenation on plasma EPO concentration [EPO], we investigated the effect of a consecutive hyperoxic and hypoxic breathing intervention. Eighteen healthy male subjects were assigned to either IHH (N = 10) or CON (N = 8) group. The IHH group breathed pure oxygen (FiO2 ~ 1.0) for 1 h, followed by a 1-h period of breathing a hypoxic gas mixture (FiO2 ~ 0.15). The CON group breathed a normoxic gas mixture (FiO2 ~ 0.21) for the same duration (2 h). Blood samples were taken just before, after 60 min, and immediately after the 2-h exposure period. Thereafter, samples were taken at 3, 5, 8, 24, 32, and 48 h after the exposure. During the breathing interventions, subjects remained in supine position. There were significant increases in absolute [EPO] within groups at 8 and 32 h in the CON and at 32 h only in the IHH group. No significant differences in absolute [EPO] were observed between groups following the intervention. Relative (∆[EPO]) levels were significantly lower in the IHH than in the CON group, 5 and 8 h following exposure. The tested protocol of consecutive hyperoxic-hypoxic gas mixture breathing did not induce [EPO] synthesis stimulation. Moreover, the transient attenuation in ∆[EPO] in the IHH group was most likely due to a hyperoxic suppression. Hence, our findings provide further evidence against the “normobaric O2 paradox” theory.
Literature
go back to reference Balestra C, Germonpre P, Poortmans J, Marroni A, Schiettecatte J, Collard JF, Snoeck T (2004) Erythropoietin production can be enhanced by normobaric oxygen breathing in healthy humans. Undersea Hyperb Med 31:53–57PubMed Balestra C, Germonpre P, Poortmans J, Marroni A, Schiettecatte J, Collard JF, Snoeck T (2004) Erythropoietin production can be enhanced by normobaric oxygen breathing in healthy humans. Undersea Hyperb Med 31:53–57PubMed
go back to reference Balestra C, Germonpre P, Poortmans JR, Marroni A (2006) Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing: the “normobaric oxygen paradox. J Appl Physiol 100:512–518PubMedCrossRef Balestra C, Germonpre P, Poortmans JR, Marroni A (2006) Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing: the “normobaric oxygen paradox. J Appl Physiol 100:512–518PubMedCrossRef
go back to reference Burk R (2007) Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO). Med Hypotheses 69:1200–1204PubMedCrossRef Burk R (2007) Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO). Med Hypotheses 69:1200–1204PubMedCrossRef
go back to reference Chapman RF, Stray-Gundersen J, Levine BD (1998) Individual variation in response to altitude training. J Appl Physiol 85:1448–1456PubMed Chapman RF, Stray-Gundersen J, Levine BD (1998) Individual variation in response to altitude training. J Appl Physiol 85:1448–1456PubMed
go back to reference De Bels D, Corazza F, Germonpre P, Balestra C (2011) The normobaric oxygen paradox: a novel way to administer oxygen as an adjuvant treatment for cancer? Med Hypotheses 76:467–470PubMedCrossRef De Bels D, Corazza F, Germonpre P, Balestra C (2011) The normobaric oxygen paradox: a novel way to administer oxygen as an adjuvant treatment for cancer? Med Hypotheses 76:467–470PubMedCrossRef
go back to reference Eckardt KU, Kurtz A (2005) Regulation of erythropoietin production. Eur J Clin Invest 35(Suppl 3):13–19PubMedCrossRef Eckardt KU, Kurtz A (2005) Regulation of erythropoietin production. Eur J Clin Invest 35(Suppl 3):13–19PubMedCrossRef
go back to reference Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA, Bauer C (1989) Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. J Appl Physiol 66:1785–1788PubMed Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA, Bauer C (1989) Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. J Appl Physiol 66:1785–1788PubMed
go back to reference Faura J, Ramos J, Reynafarje C, English E, Finne P, Finch CA (1969) Effect of altitude on erythropoiesis. Blood 33:668–676PubMed Faura J, Ramos J, Reynafarje C, English E, Finne P, Finch CA (1969) Effect of altitude on erythropoiesis. Blood 33:668–676PubMed
go back to reference Ge RL, Witkowski S, Zhang Y, Alfrey C, Sivieri M, Karlsen T, Resaland GK, Harber M, Stray-Gundersen J, Levine BD (2002) Determinants of erythropoietin release in response to short-term hypobaric hypoxia. J Appl Physiol 92:2361–2367PubMed Ge RL, Witkowski S, Zhang Y, Alfrey C, Sivieri M, Karlsen T, Resaland GK, Harber M, Stray-Gundersen J, Levine BD (2002) Determinants of erythropoietin release in response to short-term hypobaric hypoxia. J Appl Physiol 92:2361–2367PubMed
go back to reference Gunga HC, Kirsch KA, Roecker L, Kohlberg E, Tiedemann J, Steinach M, Schobersberger W (2007) Erythropoietin regulations in humans under different environmental and experimental conditions. Respir Physiol Neurobiol 158:287–297PubMedCrossRef Gunga HC, Kirsch KA, Roecker L, Kohlberg E, Tiedemann J, Steinach M, Schobersberger W (2007) Erythropoietin regulations in humans under different environmental and experimental conditions. Respir Physiol Neurobiol 158:287–297PubMedCrossRef
go back to reference Haddad JJ, Olver RE, Land SC (2000) Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 275:21130–21139PubMedCrossRef Haddad JJ, Olver RE, Land SC (2000) Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 275:21130–21139PubMedCrossRef
go back to reference Hofso D, Ulvik RJ, Segadal K, Hope A, Thorsen E (2005) Changes in erythropoietin and haemoglobin concentrations in response to saturation diving. Eur J Appl Physiol 95:191–196PubMedCrossRef Hofso D, Ulvik RJ, Segadal K, Hope A, Thorsen E (2005) Changes in erythropoietin and haemoglobin concentrations in response to saturation diving. Eur J Appl Physiol 95:191–196PubMedCrossRef
go back to reference Jelkmann W (2007) Erythropoietin after a century of research: younger than ever. Eur J Haematol 78:183–205PubMedCrossRef Jelkmann W (2007) Erythropoietin after a century of research: younger than ever. Eur J Haematol 78:183–205PubMedCrossRef
go back to reference Keramidas ME, Kounalakis SN, Debevec T, Norman B, Gustafsson T, Eiken O, Mekjavic IB (2011) Acute normobaric hyperoxia transiently attenuates plasma erythropoietin concentration in healthy males: evidence against the ‘normobaric oxygen paradox’ theory. Acta Physiol (Oxf) 202:91–98CrossRef Keramidas ME, Kounalakis SN, Debevec T, Norman B, Gustafsson T, Eiken O, Mekjavic IB (2011) Acute normobaric hyperoxia transiently attenuates plasma erythropoietin concentration in healthy males: evidence against the ‘normobaric oxygen paradox’ theory. Acta Physiol (Oxf) 202:91–98CrossRef
go back to reference Klausen T, Dela F, Hippe E, Galbo H (1993) Diurnal variations of serum erythropoietin in trained and untrained subjects. Eur J Appl Physiol Occup Physiol 67:545–548PubMedCrossRef Klausen T, Dela F, Hippe E, Galbo H (1993) Diurnal variations of serum erythropoietin in trained and untrained subjects. Eur J Appl Physiol Occup Physiol 67:545–548PubMedCrossRef
go back to reference Knaupp W, Khilnani S, Sherwood J, Scharf S, Steinberg H (1992) Erythropoietin response to acute normobaric hypoxia in humans. J Appl Physiol 73:837–840PubMed Knaupp W, Khilnani S, Sherwood J, Scharf S, Steinberg H (1992) Erythropoietin response to acute normobaric hypoxia in humans. J Appl Physiol 73:837–840PubMed
go back to reference Kokot F, Franek E, Kokot M, Wiecek A (1994a) Erythropoietin secretion in patients with chronic renal failure after pure oxygen breathing. Nephron 67:436–440PubMedCrossRef Kokot F, Franek E, Kokot M, Wiecek A (1994a) Erythropoietin secretion in patients with chronic renal failure after pure oxygen breathing. Nephron 67:436–440PubMedCrossRef
go back to reference Kokot M, Kokot F, Franek E, Wiecek A, Nowicki M, Dulawa J (1994b) Effect of isobaric hyperoxemia on erythropoietin secretion in hypertensive patients. Hypertension 24:486–490PubMed Kokot M, Kokot F, Franek E, Wiecek A, Nowicki M, Dulawa J (1994b) Effect of isobaric hyperoxemia on erythropoietin secretion in hypertensive patients. Hypertension 24:486–490PubMed
go back to reference Levine BD, Stray-Gundersen J (1997) Living high-training low: effect of moderate-altitude acclimatization with low-altitude training on performance. J Appl Physiol 83:102–112PubMed Levine BD, Stray-Gundersen J (1997) Living high-training low: effect of moderate-altitude acclimatization with low-altitude training on performance. J Appl Physiol 83:102–112PubMed
go back to reference Mackenzie RW, Watt PW, Maxwell NS (2008) Acute normobaric hypoxia stimulates erythropoietin release. High Alt Med Biol 9:28–37PubMedCrossRef Mackenzie RW, Watt PW, Maxwell NS (2008) Acute normobaric hypoxia stimulates erythropoietin release. High Alt Med Biol 9:28–37PubMedCrossRef
go back to reference McGuire A, Querido J, Fedoruk M, Wang P, Rupert J, McKenzie D (2006) Plasma erythropoietin concentration following normobaric hyperoxia. Appl Physiol Nutr Metab 31:S58 McGuire A, Querido J, Fedoruk M, Wang P, Rupert J, McKenzie D (2006) Plasma erythropoietin concentration following normobaric hyperoxia. Appl Physiol Nutr Metab 31:S58
go back to reference Ou LC, Salceda S, Schuster SJ, Dunnack LM, Brink-Johnsen T, Chen J, Leiter JC (1998) Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness. J Appl Physiol 84:1242–1251PubMed Ou LC, Salceda S, Schuster SJ, Dunnack LM, Brink-Johnsen T, Chen J, Leiter JC (1998) Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness. J Appl Physiol 84:1242–1251PubMed
go back to reference Paliege A, Rosenberger C, Bondke A, Sciesielski L, Shina A, Heyman SN, Flippin LA, Arend M, Klaus SJ, Bachmann S (2010) Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 77:312–318PubMedCrossRef Paliege A, Rosenberger C, Bondke A, Sciesielski L, Shina A, Heyman SN, Flippin LA, Arend M, Klaus SJ, Bachmann S (2010) Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 77:312–318PubMedCrossRef
go back to reference Patel TV, Singh AK (2010) Anemia in chronic kidney disease: new advances. Heart Fail Clin 6:347–357PubMedCrossRef Patel TV, Singh AK (2010) Anemia in chronic kidney disease: new advances. Heart Fail Clin 6:347–357PubMedCrossRef
go back to reference Roberts D, Smith DJ (1996) Erythropoietin does not demonstrate circadian rhythm in healthy men. J Appl Physiol 80:847–851PubMed Roberts D, Smith DJ (1996) Erythropoietin does not demonstrate circadian rhythm in healthy men. J Appl Physiol 80:847–851PubMed
go back to reference Rodriguez FA, Ventura JL, Casas M, Casas H, Pages T, Rama R, Ricart A, Palacios L, Viscor G (2000) Erythropoietin acute reaction and haematological adaptations to short, intermittent hypobaric hypoxia. Eur J Appl Physiol 82:170–177PubMedCrossRef Rodriguez FA, Ventura JL, Casas M, Casas H, Pages T, Rama R, Ricart A, Palacios L, Viscor G (2000) Erythropoietin acute reaction and haematological adaptations to short, intermittent hypobaric hypoxia. Eur J Appl Physiol 82:170–177PubMedCrossRef
go back to reference Samaja M (2001) Hypoxia-dependent protein expression: erythropoietin. High Alt Med Biol 2:155–163PubMedCrossRef Samaja M (2001) Hypoxia-dependent protein expression: erythropoietin. High Alt Med Biol 2:155–163PubMedCrossRef
go back to reference Saunders PU, Pyne DB, Gore CJ (2009) Endurance training at altitude. High Alt Med Biol 10:135–148PubMedCrossRef Saunders PU, Pyne DB, Gore CJ (2009) Endurance training at altitude. High Alt Med Biol 10:135–148PubMedCrossRef
go back to reference Savourey G, Launay JC, Besnard Y, Guinet A, Bourrilhon C, Cabane D, Martin S, Caravel JP, Pequignot JM, Cottet-Emard JM (2004) Control of erythropoiesis after high altitude acclimatization. Eur J Appl Physiol 93:47–56PubMedCrossRef Savourey G, Launay JC, Besnard Y, Guinet A, Bourrilhon C, Cabane D, Martin S, Caravel JP, Pequignot JM, Cottet-Emard JM (2004) Control of erythropoiesis after high altitude acclimatization. Eur J Appl Physiol 93:47–56PubMedCrossRef
go back to reference Stray-Gundersen J, Chapman RF, Levine BD (2001) Living high-training low altitude training improves sea level performance in male and female elite runners. J Appl Physiol 91:1113–1120PubMed Stray-Gundersen J, Chapman RF, Levine BD (2001) Living high-training low altitude training improves sea level performance in male and female elite runners. J Appl Physiol 91:1113–1120PubMed
go back to reference Tanabe N, Ohnishi K, Fukui H, Ohno R (1997) Effect of smoking on the serum concentration of erythropoietin and granulocyte-colony stimulating factor. Intern Med 36:680–684PubMedCrossRef Tanabe N, Ohnishi K, Fukui H, Ohno R (1997) Effect of smoking on the serum concentration of erythropoietin and granulocyte-colony stimulating factor. Intern Med 36:680–684PubMedCrossRef
go back to reference Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH (2010) Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 12:676–684PubMedCrossRef Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH (2010) Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 12:676–684PubMedCrossRef
Metadata
Title
Acute short-term hyperoxia followed by mild hypoxia does not increase EPO production: resolving the “normobaric oxygen paradox”
Authors
Tadej Debevec
Michail E. Keramidas
Barbara Norman
Thomas Gustafsson
Ola Eiken
Igor B. Mekjavic
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
European Journal of Applied Physiology / Issue 3/2012
Print ISSN: 1439-6319
Electronic ISSN: 1439-6327
DOI
https://doi.org/10.1007/s00421-011-2060-7

Other articles of this Issue 3/2012

European Journal of Applied Physiology 3/2012 Go to the issue